Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » Top Stories

Top Stories

Recent articles that are of ongoing interest...

Recent Articles

  WuXi NextCODE Raises $75 Million for Genomics Operations
  Week in Review: Cathay Fortune Pays $186 Million for German Diagnostic Company
  Aslan Officially Announces $40 Million Taiwan IPO
  Aire Eye Hospital Offers $166 Million for European Ophthalmology Clinics
  Tianjin CanSino Biologics Raises $65 Million for Vaccine Development
  Aslan Pharma Plans $40 Million Taiwan IPO in May
  Beijing's Creat Pays $1.3 Billion for Biotest, a German Plasma Company
  Fosun Says its M&A/Operating Strategy Designed to Meet Next-Gen Business World
  C-Bridge Capital and Tasly Invest $150 Million in Two China Biopharmas
  Ally Bridge Backs $301 Million Privatization of Luoxin Pharma